Hematopoietic stem and progenitor cells and their implication in transfusion medicine have been the main research area of Dr. Pineault. He completed his graduate studies at the University of British Columbia in Vancouver in 2001, and a post-doctoral fellowship at the Terry Fox Laboratory in 2004. Since then, Dr. Pineault has been leading various research programs in blood cell development at Canada`s two blood banks; Héma-Québec (2004-2012) and at the Canadian Blood Services (2012-present). In recent years, Dr. Pineault’s research has focused on the use of immunodeficient mice transplantation models to characterize the engraftment properties of cord blood stem and progenitors. His team test new ways to expand HSC and/or improve platelet engraftment with ex vivo expanded stem and progenitors and, characterize the impact of cord blood processing delays or new cryoprotectant agents on hematopoietic stem cells.
There are two parts to the World Advanced Therapies & Regenerative Medicine Congress: a conference and an exhibition featuring solutions for pharma and biotech.
There is a registration fee to attend the conferences. To visit the exhibition is free.